← Home
📢 Press Releases
| Date | Press release |
|---|---|
| 2026-06-11 11:30:00 | Novo Nordisk A/s: It Security Incident At Novo Nordisk BagsvÆrd, denmark, 11 june 2026 – novo nordisk a/s has identified an it security incident involving unauthorised access to a limited number of internal it systems. upon learning of the incident, we launched an investigation with the assistance of external cybersecurity experts, and we are in contact with the relevant authorities. |
| 2026-06-08 08:09:00 | Novo Nordisk A/s - Share Repurchase Programme BagsvÆrd, denmark, 8 june 2026 – on 6 may 2026, novo nordisk initiated a share repurchase programme in accordance with article 5 of regulation no 596/2014 of the european parliament and council of 16 april 2014 (mar) and the commission delegated regulation (eu) 2016/1052 of 8 march 2016 (the ’safe harbour rules’). this programme is part of the overall share repurchase programme of up to dkk 15 billion to be executed during a 12-month period beginning 4 february 2026. |
| 2026-06-03 02:00:00 | Wegovy® Pill Launches In The Uae As Novo Nordisk Expands Global Access To Obesity Care Novo nordisk is launching wegovy® pill in the uae, the first country outside the us, to make the wegovy® pill available to people living with obesity |
| 2026-06-01 07:17:00 | Novo Nordisk A/s - Share Repurchase Programme BagsvÆrd, denmark, 1 june 2026 – on 6 may 2026, novo nordisk initiated a share repurchase programme in accordance with article 5 of regulation no 596/2014 of the european parliament and council of 16 april 2014 (mar) and the commission delegated regulation (eu) 2016/1052 of 8 march 2016 (the ’safe harbour rules’). this programme is part of the overall share repurchase programme of up to dkk 15 billion to be executed during a 12-month period beginning 4 february 2026. |
| 2026-05-28 08:27:00 | Completion Of Tranche 2 Of Placement Not for release to us wire service or distribution in the united states perth, australia, may 28, 2026 (globe newswire) -- novo resources corp. (“novo” or the “company”) (asx: nvo) (tsx: nvo) (otcqb: nsrpf) is pleased to announce that tranche 2 of the placement it announced on 24 and 26 february 2026 (vancouver)/25 and 26 february 2026 (perth) (“placement”) completed today following shareholder approval that was received at the company’s annual general meeting (“agm”) held on 21 may 2026 (vancouver)/22 may 2026 (perth). the company received gross proceeds of ~c$1.93m (approximately a$1.95m) through the issue of the following securities under tranche 2 of the placement: ~8.0m units at c$0.10 per unit to investors in canada (with each unit comprising one common share of novo (each, a “common share”) and one-half (0.5) common share purchase warrant (“unit”)); and ~10.9m chess depository interests (“cdis”) at a$0.105 per cdi to investors outside of canada, together with the right to receive one option to purchase one cdi (each an “option”) for every two cdi’s subscribed for under the placement, each option entitling the holder to purchase one cdi at a price of a$0.15 for a period of three years (with one common share underlying each cdi). |
| 2026-05-26 10:16:00 |
|
| 2026-05-26 04:41:00 |
|
| 2026-05-22 13:30:00 |
|
| 2026-05-22 09:09:00 |
|
| 2026-05-18 09:38:00 |
|
| 2026-05-13 02:00:00 |
|
| 2026-05-12 10:49:00 |
|
| 2026-05-12 06:25:00 |
|
| 2026-05-12 02:00:00 |
|
| 2026-05-06 01:31:00 |
|
📰 Browse additional press releases for Novo Nordisk!
Sign up for free or log in✍️ Sign up to get "The Checklist Value Investor — A Smarter Way to Pick Stocks" for free